Adverse events and SLE disease activity following HZ vaccine.
| SLE | Healthy | |
|---|---|---|
| HZ, n | 0 | 0 |
| Serious adverse event, n | 0 | 0 |
| ISR (any), n | 3 | 3 |
| Erythema, tenderness, n | 3 | 3 |
| Vesicular lesions, n | 0 | 0 |
| 2-week SLEDAI, median (range) | 0 (0–3) | — |
| 6-week SLEDAI, median (range) | 1 (0–3) | — |
| 12-week SLEDAI, median (range) | 0 (0–3) | — |
| SLE flare, n | 0 | — |
ISR: injection site reaction; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; HZ: herpes zoster.